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SUMMARY  
Resistance exercise, amino acid ingestion and an anabolic hormone environment all 
have the capacity to elevate muscle protein synthesis (MPS), while a catabolic 
hormone environment, such as elevated pro-inflammatory cytokines as seen during 
disuse, aging, and conditions such as cancer and AIDS, can cause an increase in 
muscle protein degradation (MPD). When the rate of MPS exceeds that of MPD there 
is a positive net protein balance (NPB) and over a prolonged period of time this 
results in accretion of contractile material and muscle growth, or hypertrophy. In 
contrast, when NPB is chronically negative, muscle atrophy occurs, i.e. muscle size 
decreases. Various signaling pathways within the muscle fiber appear to play a crucial 
role in the adaptive processes, and understanding how these pathways can be 
modulated will help the design of therapies to prevent or reverse muscle atrophy in a 
host of muscle wasting conditions. 
 
Key words: skeletal muscle – protein synthesis – hypertrophy – atrophy – IGF-I – 
mTOR – cytokine – TNF- – interleukin – myostatin 
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INTRODUCTION 
Skeletal muscle comprises numerous bundles of long, thin, multinucleated cells called 
muscle fibers, each containing a multitude of myofibrils. Each myofibril is composed 
of myofilaments (comprising the contractile proteins, actin and myosin) and a variety 
of structural proteins, all arranged in a regular configuration throughout the length of 
the myofibril, so as to form a series of contractile components, or sarcomeres. The 
maximum force that can be generated by a muscle fiber is proportional to the number 
of sarcomeres arranged in parallel, or fiber cross-sectional area (CSA), and ultimately 
the CSA of the whole muscle (Jones, Rutherford, Parker, 1989). Therefore, there is a 
strong relationship between whole muscle CSA and maximum isometric force 
measured in vivo (Bamman, Newcomer, Larson-Meyer, Weinsier, Hunter, 2000; 
Fukunaga et al., 2001; Kanehisa, Ikegawa, Fukunaga, 1994).  
 
Based on the relationship between muscle size and force generating capacity (Erskine, 
Fletcher, Folland, 2014), it is not surprising that an increase in muscle size following 
resistance training (RT) is accompanied by an increase in maximal muscle force 
(Erskine, Jones, Williams, Stewart, Degens, 2010b; Jones, Rutherford, 1987; Narici et 
al., 1996). Not only can this enhance the athletic performance of an individual but it 
can also reduce the elevated risk of falling and bone fracture in older people that is 
among other factors attributable to sarcopenia (the age-related loss of muscle mass). 
The question thus arises as to the mechanisms underlying overload-induced muscle 
hypertrophy.  
 
A multitude of signaling molecules within the muscle fiber are thought to play an 
integral role in stimulating muscle protein synthesis (MPS) and degradation (MPD). If 
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there is a positive net protein balance (NPB), i.e. when the rate of MPS exceeds that 
of MPD, the amount of contractile material will increase, enabling the muscle to 
hypertrophy and generate more force. Conversely, when NPB is negative, the muscle 
will decrease in size, or atrophy, and become weaker. This chapter will explore the 
specific signaling pathways involved in MPS and MPD, which help to explain how 
skeletal muscle adapts to overload, disuse, ageing and muscle-wasting diseases. 
Furthermore, strategies used to preserve or maintain muscle mass during periods of 
disuse and wasting, such as RT and nutritional interventions, will be discussed.  
 
In addition to the mechanisms underlying muscle growth and atrophy, there is still 
more to be learned about the systems associated with repair following exercise-
induced muscle damage. Several studies have reported that disruption of the 
cytoskeletal structure of muscle fibers is accompanied by impairment of muscular 
function following damage-inducing exercise (Baumert, Lake, Stewart, Drust, 
Erskine, 2016; Friden, Sjostrom, Ekblom, 1983; Lieber, Shah, Friden, 2002). As well 
as structural damage to the sarcomere, eccentric exercise can cause raised intracellular 
calcium ion (Ca2+) levels (Belcastro, Albisser, Littlejohn, 1996), decreased muscle 
force production (Clarkson, Sayers, 1999; Friden et al., 1983), an increase in serum 
levels of muscle-specific proteins (Ebbeling, Clarkson, 1989), an increase in muscle 
specific inflammation (MacIntyre, Reid, McKenzie, 1995), an increase in proteolytic 
enzyme activity (Evans, Cannon, 1991), and a delayed-onset muscle soreness 
(MacIntyre et al., 1995). The ultimate repair of the muscle requires the activation of 
satellite cells and in this chapter we will consider the various MPD systems and the 
role of satellite cells thought to play a major role in muscle damage and repair 
following exercise. 
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MUSCLE GROWTH 
While prenatal muscle growth is largely the result of muscle fiber formation, postnatal 
maturational muscle growth and that in response to RT is almost entirely attributable 
to fiber hypertrophy. Prenatal myogenesis, i.e. the formation of muscle fibers during 
embryonic development, involves the proliferation, migration, differentiation and 
fusion of muscle precursor cells to form post-mitotic multinucleated myotubes. 
Postnatal skeletal muscle growth is accompanied by an increase in the number of 
myonuclei per muscle fiber (Delhaas, van der Meer, Schaart, Degens, Drost, In Press) 
that requires the activation of muscle stem cells, or satellite cells (located at the basal 
lamina that surrounds the muscle fiber), which proliferate and fuse with existing 
muscle fibers (Jacquemin, Furling, Bigot, Butler-Browne, Mouly, 2004). Once fully 
mature, skeletal muscle growth, or hypertrophy, is dependent upon a positive NPB, 
i.e. MPS must be greater than MPD (Chesley, MacDougall, Tarnopolsky, Atkinson, 
Smith, 1992; Phillips, Tipton, Aarsland, Wolf, Wolfe, 1997), a process that is driven 
by an increase in the rate of MPS (Kumar, Atherton, Smith, Rennie, 2009). This leads 
to an accretion of myofibrillar proteins and an increase in muscle fiber CSA, which in 
turn leads to an increase in the overall CSA of the muscle, thus enabling more force to 
be produced. Resistance exercise, i.e. overloading the muscle, has been shown to 
increase MPS (Chesley et al., 1992; Phillips et al., 1997), and chronic resistance 
exercise, i.e. RT performed over many weeks, is a potent stimulus for skeletal muscle 
hypertrophy and strength gains (Erskine et al., 2010b; Jones et al., 1987; Narici et al., 
1996). However, exactly how overloading the muscle leads to a positive NPB and 
therefore an increase in muscle size has yet to be fully elucidated. It is thought that the 
process necessary for inducing muscle hypertrophy involves a myriad of molecules 
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within the muscle fiber that form signaling cascades, eventually culminating in 
increased MPS and/or decreased MPD. Here we will discuss how insulin-like growth 
factor-I (IGF-I), mechanosensors, and amino acids might activate these specific 
signaling pathways that lead to MPS and ultimately to muscle growth, or hypertrophy.  
 
The role of IGF-I in muscle growth 
IGF-I is produced by the liver and skeletal muscle and thus acts on muscle fibers in an 
endocrine and autocrine/paracrine manner (Goldspink, 1999; Stewart, Rotwein, 
1996). This growth factor appears to play an integral role in activating a specific 
signaling pathway within the muscle fiber that stimulates MPS (Bodine et al., 2001; 
Rommel et al., 2001). The local production and release of IGF-I during muscle 
contraction (DeVol, Rotwein, Sadow, Novakofski, Bechtel, 1990) activates this 
signaling cascade by binding to its receptor, located in the sarcolemma. This causes 
autophosphorylation of the insulin receptor substrate (IRS1) and subsequent 
phosphorylation of down-stream molecules within this signaling pathway, which 
includes phosphatidylinositol-3 kinase (PI3K), protein kinase-B (PKB or Akt), the 
mammalian target of rapamycin complex 1 (mTORC1), 70-kDa ribosomal S6 protein 
kinase (p70S6K), and eukaryotic initiation factor 4E binding protein (4E-BP) (Fig. 1). 
In fact, p70S6K activation is related to gains in skeletal muscle mass following RT, 
both in rats (Baar, Esser, 1999) and humans (Terzis et al., 2008), with the increase 
occurring mainly in type II fibers (Koopman, Zorenc, Gransier, Cameron-Smith, van 
Loon, 2006). Together, these studies implicate mTORC1 and p70S6K as principal 
downstream mediators of IGF-I stimulation of skeletal muscle growth.  
 
[FIGURE 1 NEAR HERE] 
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There is evidence that IGF-I produced in skeletal muscle is more important for 
developmental and exercise-induced muscle growth than IGF-I produced by the liver. 
This is indicated by the greater muscle mass in transgenic mice over-expressing IGF-I 
in skeletal muscle compared to wild-type mice (Coleman et al., 1995; Musaro et al., 
2001) despite normal serum IGF-I levels (Coleman et al., 1995). Furthermore, low 
systemic IGF-I levels in liver-specific IGF-I knockout mice does not affect muscle 
size (Ohlsson et al., 2009; Yakar et al., 1999). Also in young adult men, elevated 
levels of circulating IGF-I do not influence MPS following an acute bout of resistance 
exercise (West et al., 2009) or muscle hypertrophy in response to RT (West et al., 
2010). Although in rat skeletal muscle, local IGF-I gene expression increases 
proportionately to the progressive increase in external load (DeVol et al., 1990), it is 
equivocal whether this occurs in human muscle (Bamman et al., 2001; Bickel et al., 
2005; Bickel, Slade, Haddad, Adams, Dudley, 2003; Hameed, Orrell, Cobbold, 
Goldspink, Harridge, 2003; Petrella, Kim, Cross, Kosek, Bamman, 2006; Psilander, 
Damsgaard, Pilegaard, 2003). Some of this controversy might be explained by the 
elevated expression of two isoforms of the Igf1 gene in animal skeletal muscle in 
response to mechanical stimulation (McKoy et al., 1999; Yang, Alnaqeeb, Simpson, 
Goldspink, 1996). Thus, at least two IGF-I isoforms exist: (i) IGF-IEa, which is 
similar to the hepatic endocrine isoform, and (ii) the less abundant IGF-IEb (in rats) 
or IGF-IEc (in humans), otherwise known as mechanical growth factor (MGF). 
However, it is not always clear which IGF-I isoform has been measured in the muscle 
(Bamman et al., 2001). Furthermore, the age of the participants also influences the 
findings, with MGF increasing in young but not old people following an exercise 
bout. Interestingly, IGF-IEa does not appear to change in young or older people 
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following resistance exercise (Hameed et al., 2003), despite its apparent hypertrophic 
effect (Musaro et al., 2001).  
 
Skeletal muscle-derived IGF-I does not appear to be the only regulator of adult 
muscle mass and function, as unloading induces skeletal muscle atrophy in mice 
whose muscles over-express IGF-I (Criswell et al., 1998), and overload induces 
hypertrophy even in transgenic mice, which express a dominant negative IGF-I 
receptor in skeletal muscle (Spangenburg, Le Roith, Ward, Bodine, 2008). Also in 
older people, enhanced muscle strength can be attained following RT without a 
significant change in muscle IGF-I gene expression (Taaffe, Jin, Vu, Hoffman, 
Marcus, 1996). Thus, it appears that for the development of hypertrophy in adult 
muscles, loading is more important than alterations in local and systemic IGF-I levels. 
This fits the notion that activation of mTORC1 and p70S6K can also occur 
independently of PI3K activation following muscle overload (Hornberger, Sukhija, 
Wang, Chien, 2007).  
 
The role of mechanosensors in muscle growth 
The process that couples the mechanical forces during a muscle contraction with cell 
signaling and ultimately protein synthesis is called mechanotransduction. It has been 
shown in rats that passive stretch induces an increase in the expression of myogenic 
regulatory factors (Kamikawa, Ikeda, Harada, Ohwatashi, Yoshida, 2013) that may 
well underlie the muscle fiber atrophy seen after passive stretching (Coutinho, 
DeLuca, Salvini, Vidal, 2006). These responses are probably at least partly mediated 
by stretch-activated channels (SACs), which are calcium (Ca2+) and sodium 
permeable channels that increase their open probability (the fraction of time spent in 
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the open state) in response to mechanical loading of the sarcolemma (Franco, 
Lansman, 1990a; Franco, Lansman, 1990b; Guharay, Sachs, 1984). It has been 
proposed that SACs function as mechanosensors by allowing an influx of Ca2+ into 
the muscle fiber (Yeung et al., 2005) following mechanical changes in the 
sarcolemma, which activate mTORC1 (Gulati et al., 2008), leading to an increase in 
MPS (Kameyama, Etlinger, 1979). Correspondingly, inhibition of SACs by 
streptomycin reduces skeletal muscle hypertrophy in response to mechanical overload 
(Butterfield, Best, 2009; Spangenburg, McBride, 2006) via attenuation of mTORC1 
and p70S6K activation (Spangenburg et al., 2006).  
 
Other mechanosensors might exist in the form of costameres, intra-sarcolemmal 
protein complexes that are circumferentially aligned along the length of the muscle 
fiber (Pardo, Siliciano, Craig, 1983). Costameres mechanically link peripheral 
myofibrils via the Z-disks to the sarcolemma (Fig. 2), thus maintaining the integrity of 
the muscle fiber during contraction and relaxation (Pardo et al., 1983). An individual 
costamere contains many proteins arranged in a complex structure (Ervasti, 2003; 
Patel, Lieber, 1997), which comprises two different laminin receptors, a 
dystrophin/glycoprotein complex and an integrin-associated complex, which are 
localised in the sarcolemma and bound to intra and extra-cellular structural proteins 
(Fig. 2). Thus, the force-producing contractile material is connected to the basal 
membrane and ultimately to adjacent muscle fibers (Morris, Fulton, 1994; Patel et al., 
1997; Rybakova, Patel, Ervasti, 2000).  
 
[FIGURE 2 NEAR HERE] 
 
 10 
Costameres are receptive to mechanical, electrical and chemical stimuli (Ervasti, 
2003). Indeed, mechanical tension is essential in regulating costameric protein 
expression, stability and organization, with talin and vinculin, for instance, being up-
regulated in response to muscle contraction (Tidball, Spencer, Wehling, Lavergne, 
1999). Regular contractions, as experienced during RT, increase the expression of 
costameric proteins, such as desmin (Woolstenhulme, Conlee, Drummond, Stites, 
Parcell, 2006), alpha-1-syntrophin and dystrophin (Kosek, Bamman, 2008) in 
humans, while focal adhesion kinase (FAK) and paxillin activity are increased in 
stretch-induced hypertrophied avian skeletal muscle (Fluck, Carson, Gordon, 
Ziemiecki, Booth, 1999). The forces exerted on both the intracellular contractile 
proteins and the basal membrane during periods of loading are required to cause 
binding of basal membrane laminin to the receptors on the  and  integrins and on 
the dystrophin/glycoprotein complex (Fluck, Ziemiecki, Billeter, Muntener, 2002). 
Interaction between integrins and the extra-cellular matrix causes rapid 
phosphorylation of FAK (Cary, Guan, 1999), which subsequently activates p70S6K 
independently of Akt (Durieux et al., 2009; Klossner, Durieux, Freyssenet, Flueck, 
2009). This probably occurs via the phosphorylation and, thus, inactivation of 
tuberous sclerosis complex 2 (Gan, Yoo, Guan, 2006; Malik, Parsons, 1996), thus 
activating mTORC1 as shown in Fig. 1.  
 
The role of amino acids in muscle growth 
Both resistance exercise (Biolo, Maggi, Williams, Tipton, Wolfe, 1995; Phillips et al., 
1997) and amino acid/protein ingestion (Tang, Moore, Kujbida, Tarnopolsky, Phillips, 
2009; Yang et al., 2012b) stimulate MPS independently, while a combination of the 
two augments MPS even further (Biolo, Tipton, Klein, Wolfe, 1997; Tipton, 
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Ferrando, Phillips, Doyle, Wolfe, 1999). Both stimuli cause an increase in mTORC1 
activation (Apro, Blomstrand, 2010; Moore, Atherton, Rennie, Tarnopolsky, Phillips, 
2011) but it is unclear whether they stimulate MPS via different signaling pathways, 
or whether the combination of the two stimulates the same pathway more than either 
stimulant on its own. It is thought that amino acids cause Rag GTPases to interact 
with raptor (a regulatory protein associated with mTORC1), leading to the 
translocation of mTORC1 to the lysosomal membrane, where Rheb (a Ras GTPase) 
activates mTORC1 (Kim, Guan, 2009; Sancak et al., 2010; Sancak et al., 2008), as 
shown in Fig. 1. Of the essential amino acids (EAAs), the branched-chain amino acids 
(BCAAs: isoleucine, leucine, and valine), and particularly leucine, are the most potent 
stimulators of the mTORC1 signaling pathway (Anthony et al., 2000). Leucine 
supplementation stimulates muscle protein accretion in cultured cells (Haegens, 
Schols, van Essen, van Loon, Langen, 2012) and can also reduce MPD in healthy men 
(Nair, Schwartz, Welle, 1992), and it is possible that the action of leucine occurs via 
its metabolite, β-hydroxy-β-methylbutyrate (HMB) (Aversa et al., 2011; Pimentel et 
al., 2011).  
 
The timing of amino acid ingestion appears crucial for an optimal anabolic response 
to a single bout of resistance exercise: ingesting amino acids immediately before an 
exercise bout promotes a greater increase in MPS compared to ingestion immediately 
after the bout (Tipton et al., 2001). This effect was attributed to an increased blood 
flow during exercise, and therefore an increased delivery of amino acids to the active 
muscle when they were ingested prior to exercise (Tipton et al., 2001). As well as the 
timing, the amount of protein ingested is integral in producing an optimal anabolic 
environment following resistance exercise (Moore et al., 2009; Witard et al., 2014; 
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Yang et al., 2012a). For example, the MPS dose response to ingested protein after a 
single bout of resistance exercise in healthy young men is saturated at 20 g protein, 
and any additional ingested protein is simply oxidized (Moore et al., 2009; Witard et 
al., 2014). This suggests that if the rate of protein ingestion after resistance exercise 
exceeds the rate at which it can be incorporated into the muscle, the excess protein is 
not used for MPS. This dose-response relationship seems to be altered with age, as in 
older men increased rates of MPS were found when participants ingested 40 g protein 
following a resistance exercise bout (Yang et al., 2012a). Therefore, older muscle 
appears to be less sensitive to amino acids, which has been termed ‘anabolic 
resistance’, something that may be attributable to impaired ribosome genesis in older 
muscle (Chaillou, 2017). Finally, the type and quality of the ingested protein appears 
to be important when it comes to MPS (Tang et al., 2009; Yang et al., 2012b). 
Following a single bout of resistance exercise and the ingestion of whey, soy or 
casein, each containing 10 g EAA, larger increases in blood EAA, BCAA, and leucine 
concentrations were found following the ingestion of whey compared to either soy or 
casein (Tang et al., 2009), suggesting a greater availability of these amino acids for 
protein synthesis following whey protein ingestion. This may be a reflection of the 
different rate of protein digestion and absorption of amino acids between the protein 
types (Boirie et al., 1997; Dangin et al., 2001; Dangin et al., 2003) and explain why 
MPS was greater following ingestion of whey compared to casein, both at rest and 
after exercise (Tang et al., 2009). In older muscle, the rate of MPS appears to be 
greater with whey than soy protein ingestion following resistance exercise (Yang et 
al., 2012b), which could be due to the ~28% greater leucine content in whey versus 
soy protein (Drummond, Rasmussen, 2008) as well as differences in digestion and 
absorption rate.  
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There is therefore striking evidence to support the acute effects of amino acid 
ingestion and resistance exercise on MPS via their independent and complementary 
effects on mTORC1 activation. It is also well known that repeated bouts of resistance 
exercise over a prolonged period of time, i.e. a RT program, leads to gains in both 
muscle size and strength (Erskine et al., 2010b; Jones et al., 1987; Narici et al., 1996). 
Therefore, the amplification of the anabolic environment within the muscle seen with 
the combination of both amino acid/protein ingestion and resistance exercise (Biolo et 
al., 1997; Tipton et al., 1999) suggests that RT with protein supplementation should 
confer greater gains in skeletal muscle size and strength than RT alone. However, the 
evidence for protein supplementation enhancing the increases in muscle size and 
strength following longer term RT programs in young (Erskine, Fletcher, Hanson, 
Folland, 2012; Hartman et al., 2007) and older (Candow et al., 2008; Verdijk et al., 
2009b) individuals is equivocal. The controversy surrounding the longer-term RT 
studies could be due to methodological differences/limitations between studies. For 
example, considerable inter-individual variability exists in the response to RT 
(Erskine, Jones, Williams, Stewart, Degens, 2010a; Hubal et al., 2005) and yet many 
studies have used small sample sizes (Godard, Williamson, Trappe, 2002; Hulmi et 
al., 2009; Willoughby, Stout, Wilborn, 2007) that may have limited the statistical 
power required to detect an influence of protein supplementation. Different measures 
of muscle hypertrophy may also compound this discrepancy. For example, some 
studies have determined muscle thickness using ultrasonography (Candow et al., 
2008; Vieillevoye, Poortmans, Duchateau, Carpentier, 2010) or whole body fat-free 
mass assessed via dual-energy X-ray absorptiometry (Hartman et al., 2007), while 
others have used magnetic resonance imaging to provide a more precise assessment of 
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muscle size, but still found no effect of protein supplementation on muscle 
hypertrophy following RT (Coburn et al., 2006; Erskine et al., 2012; Holm et al., 
2008; Hulmi et al., 2009). There are, however, circumstances where protein 
supplementation may have a beneficial effect on muscle hypertrophy and strength 
gains. For example, whole body RT (incorporating multiple muscle groups rather than 
an individual muscle) could create a requirement for an increase in exogenous protein 
(due to a greater absolute MPD) that might not be satisfied by habitual protein intake 
alone. This might be particularly beneficial in the early phase of a RT program when 
MPS and MPD are likely to be higher than towards the end (Hartman, Moore, 
Phillips, 2006; Phillips, Tipton, Ferrando, Wolfe, 1999). In addition, older individuals 
need to ingest at least twice as much protein (40 g) to maximally stimulate MPS 
(Moore et al., 2015; Yang et al., 2012a) compared to the 20 g dose in younger people 
(Moore et al., 2009; Witard et al., 2014), which may reflect an ‘anabolic resistance’ in 
old age. Therefore, previous studies that have not shown a beneficial effect of protein 
supplementation on muscle size and strength gains in older people may have been 
administering suboptimal amounts and types of protein per RT session. In frail elderly 
individuals, whose protein requirements are probably higher than in old, healthy 
people, more recent evidence supports the combination of 60 g/day milk protein 
supplementation and resistance exercise (twice weekly for six months) in increasing 
total leg lean mass composition over resistance training alone (Tieland et al., 2012). 
 
MUSCLE ATROPHY 
Skeletal muscle atrophy is known to occur in response to disuse and numerous 
chronic conditions, such as cancer, AIDS, and senile sarcopenia (the age-related loss 
of muscle mass). Here we will focus on the mechanisms underlying sarcopenia, which 
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is the major cause of muscle weakness in older individuals (Evans, 1995). Although 
the causes of sarcopenia are not fully understood, disuse, chronic systemic 
inflammation and neuropathic changes leading to motoneuron death are thought to 
play an integral role (Degens, 2010). Motoneuron death results in denervation of 
muscle fibers, and ultimately the loss of muscle fibers (hypoplasia). Selective atrophy 
of type II fibers (Lexell, Taylor, Sjostrom, 1988) and a decrease in the proportion of 
type II fibers (Jakobsson, Borg, Edstrom, Grimby, 1988; Larsson, 1983; Larsson, 
Sjodin, Karlsson, 1978) are thought to be caused by denervation accompanied by 
reinnervation of these fibers by axonal sprouting from adjacent slow-twitch motor 
units (Brooks, Faulkner, 1994; Faulkner, Larkin, Claflin, Brooks, 2007).  
 
Chronic low-grade inflammation and sarcopenia 
Physiological aging is associated with chronic low-grade inflammation, a condition 
that has been termed ‘inflammaging’ (Franceschi et al., 2000). Inflammaging is 
characterized by elevated serum levels of pro-inflammatory cytokines such as 
interleukin 1 (IL-1), IL-6  and tumor necrosis factor- (TNF-), as well as acute 
phase proteins such as C-reactive protein, or CRP (Bartlett et al., 2012; Erskine et al., 
2017; Franceschi et al., 2000), and increased circulating levels are associated with 
lower muscle mass and weakness in old age (Erskine et al., 2017; Visser et al., 2002). 
Furthermore, the levels of cytokines that counteract the inflammatory state, such as 
IL-10, are reduced with age (Bartlett et al., 2012; Lio et al., 2002). The pro-
inflammatory cytokines, IL-1, IL-6 and TNF- are produced by both skeletal muscle 
fibers and adipose cells, and are therefore also members of the adipokine family. As 
we age, we accumulate more adipose tissue, which is deposited in the subcutaneous, 
visceral and intramuscular regions, and it is particularly the visceral fat that appears to 
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contribute to the inflammatory environment (Pedersen, 2009).  
 
TNF- induces the production of reactive oxygen species (ROS), altering vascular 
permeability, which leads to leukocyte infiltration of the muscle fiber (Evans et al., 
1991) and further ROS generation by the leucocytes. This release of ROS also 
activates NF-κB via degradation of I-κB (Fig. 1), which results in the increased 
expression of key enzymes of the ubiquitin-proteasome MPD system (Li, Schwartz, 
Waddell, Holloway, Reid, 1998). In addition, TNF- interferes with satellite cell 
differentiation and therefore muscle growth and regeneration in old age by reducing 
the expression of myogenic regulatory factors (MRFs) (Degens, 2010). The MRFs are 
a family of muscle-specific transcription factors (MyoD, myogenin, MRF4 and myf-
5) that regulate the transition from proliferation to differentiation of the satellite cell 
(Langen et al., 2004; Szalay, Razga, Duda, 1997). The TNF--induced activation of 
NF-κB results in a loss of MyoD mRNA (Guttridge, Mayo, Madrid, Wang, Baldwin, 
2000) and, via activation of the ubiquitin–proteasome pathway (UPP) (Reid, Li, 2001; 
Saini, Al-Shanti, Faulkner, Stewart, 2008), breakdown of MyoD and myogenin. Thus, 
part of the attenuated hypertrophic response in elderly compared to younger muscle 
(Welle, Totterman, Thornton, 1996) could be due to a decrease in MRFs, as seen in 
overload-induced hypertrophy in older rats (Alway, Degens, Krishnamurthy, Smith, 
2002a). TNF- also stimulates the release of proteolytic enzymes, such as lysozymes 
(e.g. cathepsin-B) from neutrophils (Farges et al., 2002), which are thought to 
contribute to the MPD process (Friden, Kjorell, Thornell, 1984; Kasperek, Snider, 
1985), but the main action of the pro-inflammatory cytokines in muscle atrophy is 
thought to occur via the UPP.  
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It has been suggested that the UPP cannot breakdown intact sarcomeres, so additional 
mechanisms are proposed to be involved (Solomon, Baracos, Sarraf, Goldberg, 1998). 
For example, the activation of caspase-3 is thought to lead to cleavage of the 
myofilaments, actin and myosin, which are then degraded by the UPP (Du et al., 
2004; Lee et al., 2004; Ottenheijm et al., 2006). The UPP involves numerous 
enzymes, or ligases, that regulate the ubiquitination (the coupling of ubiquitin to 
protein substrates), so that the ‘tagged’ protein fragments can be identified by the 
proteasome for the final step of MPD (DeMartino, Ordway, 1998). These ubiquitin 
ligases may also degrade MyoD and inhibit subsequent satellite cell activation and 
differentiation (see above), thus exacerbating the effects of MPD on muscle size by 
impairing satellite cell associated muscle growth. Expression of two genes that encode 
the E3 ubiquitin ligases, muscle-specific atrophy F box (MAFbx, also known as 
Atrogin-1) and muscle RING Finger 1 (MuRF1), has been shown to increase during 
different types of muscle atrophy (Gomes, Lecker, Jagoe, Navon, Goldberg, 2001; 
Lecker et al., 2004). The structure and function of the UPP will be discussed in more 
detail, below, with regard to muscle damage and repair following exercise.  
 
The role of myostatin in muscle atrophy 
Myostatin, otherwise known as growth differentiation factor-8 (GDF-8), is part of the 
transforming growth factor β superfamily and is produced in skeletal muscle. The role 
of myostatin as a negative regulator of muscle mass has been demonstrated by 
knocking out the gdf-8 gene in mice, which leads to a 2-3 fold increase in skeletal 
muscle mass (McPherron, Lawler, Lee, 1997). Conversely, administering myostatin to 
wild-type mice induces substantial muscle wasting (Zimmers et al., 2002). Further 
examples of myostatin’s regulatory effect can be seen in bovine (McPherron, Lee, 
 18 
1997) and human (Schuelke et al., 2004) cases, where mutation of the gdf -8 gene 
leads to a reduction in myostatin production and considerably enlarged skeletal 
muscles.  
 
Once bound to the activin IIB receptor (ActRIIB), a signaling cascade is activated that 
leads to MPD. Key signaling proteins in this pathway include SMAD 2 and 3 (Sartori 
et al., 2009), which form a complex with SMAD 4 that then translocates to the 
nucleus where it targets genes encoding MRFs (Rodino-Klapac et al., 2009), and 
inhibits differentiation via the reduction of MyoD expression (Langley et al., 2002) 
(Fig. 1). In addition, myostatin reduces Akt/ mTORC1/p70S6K signaling (Amirouche 
et al., 2009; Trendelenburg et al., 2009) (Fig. 1) and is associated with smaller 
myotube size (Trendelenburg et al., 2009). Accordingly, the inhibition of myostatin in 
mature mice leads to increased activation of p70S6K, ribosomal protein S6 and skeletal 
muscle MPS (Welle, Burgess, Mehta, 2009). Myostatin appears to not only inhibit 
satellite cell differentiation and MPS, but also to induce the expression of atrogenes 
(genes associated with muscle atrophy) via activation of the p38 mitogen-activated 
protein (MAP) kinase, Erk1/2, Wnt and c-Jun N-terminal kinase (JNK) signaling 
pathways (Huang et al., 2007; Philip, Lu, Gao, 2005; Yang et al., 2006) (Fig. 1). This 
is in accord with the observation that myostatin induces cachexia by activating the 
UPP, i.e. phosphorylating the ubiquitin E3 ligases MAFbx and MuRF1, via FOXO1 
activation rather than via the NF-κB pathway (McFarlane et al., 2006). However, 
myostatin-induced atrophy persists despite inhibiting the expression of the two E3 
ligases (Trendelenburg et al., 2009). Therefore, it is likely that myostatin negatively 
regulates muscle growth via multiple pathways (Fig. 1). A lower expression of 
myostatin may therefore help to maintain muscle mass at old age, a situation reflected 
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by the attenuated loss of muscle mass and regenerative capacity in old myostatin-null 
mice compared to age-matched wild-type mice (Siriett et al., 2006).  
 
Combating sarcopenia 
RT has been shown to increase muscle size and strength in old (Reeves, Narici, 
Maganaris, 2004), very old (Harridge, Kryger, Stensgaard, 1999) and frail (Fiatarone 
et al., 1994) individuals. This beneficial effect of RT is attributable to an increase in 
MPS in the atrophied muscle (Kimball, O'Malley, Anthony, Crozier, Jefferson, 2004) 
and a reduction in MPD as a result of a reduced MAFbx and MuRF-1 gene expression 
(Jones et al., 2004; Mascher et al., 2008). A reduction in atrogene expression can be 
realized by the ability of phosphorylated Akt to block FoxO1, which would suppress 
the transcription of MuRF1 and MAFbx (Sandri et al., 2004), as shown in Fig. 1. In 
addition to the Akt/FoxO-1 pathway, mTORC1 also blocks MuRF1 and MAFbx 
transcription (Sandri et al., 2004). Therefore, while a degree of MPD is required for 
muscle remodeling, RT appears to reverse atrophy via the inhibiting effect of 
Akt/mTORC1 on MPD and the positive effect of mTORC1 activation on MPS (Apro 
et al., 2010; Moore et al., 2011), thus resulting in net protein synthesis (albeit to a 
lesser extent in elderly compared to younger muscle).  
 
The apparent ‘anabolic resistance’ to RT in older compared to young muscle (Kimball 
et al., 2004; Welle et al., 1996) may not be due to an age-related reduction in the 
mechanosensitivity of the mTORC1 signaling pathway (Hornberger, Mateja, Chin, 
Andrews, Esser, 2005), although others do see a reduction in the translational 
signaling during overload (Thomson, Gordon, 2006). It could therefore be that the 
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rates of transcription and translation are reduced during overload, which may be a 
consequence of impaired ribosome biogenesis in older muscle (Chaillou, 2017).  
 
Another factor that might be considered is the proposed requirement of satellite cell 
recruitment for the development of hypertrophy. An impaired satellite cell recruitment 
would then result in impaired hypertrophy and part of the problem might be a decline 
in satellite cell number (Shefer, Van de Mark, Richardson, Yablonka-Reuveni, 2006), 
particularly in type II muscle fibers of older people (Verdijk et al., 2007). Yet, 
paradoxically, older muscle appears to have an increased regenerative drive and 
protein synthesis that is more pronounced the more severe the sarcopenia. For 
instance, muscle mass is lower despite higher p70S6K activation and MPS in old 
compared to young adult rats (Kimball et al., 2004). IGF-I appears to play a key role 
in the activation and proliferation of satellite cells (Scime, Rudnicki, 2006), while 
differentiation is regulated by MRFs (Langen et al., 2004; Szalay et al., 1997). 
However, despite an increased regenerative drive as reflected by elevated IGF-I 
expression (Edstrom, Ulfhake, 2005) and MRF mRNA expression (Alway, Degens, 
Lowe, Krishnamurthy, 2002b) in old rat muscle, MRF protein levels are reduced 
(Alway et al., 2002b). This reduction might be caused by a concomitant increase in Id 
protein expression (Alway et al., 2002b), which inhibits MRF expression and DNA 
binding capacity. The result is that during an hypertrophic stimulus, satellite cell 
activation and proliferation can occur in older rat skeletal muscle but with limited 
differentiation (Edstrom et al., 2005). In elderly human skeletal muscle, however, the 
capacity for satellite cells to proliferate and differentiate in response to RT does not 
appear to be diminished (Mackey et al., 2007; Verdijk et al., 2009a). It should be 
noted, however, that the relative age in the human studies was less than that in the rat 
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studies and it may be that beyond a given age in humans, the differentiation of 
satellite cells may also be diminished, particularly when associated with chronic low-
grade systemic inflammation.  
 
Although satellite cells are generally considered to play an important role in muscle 
hypertrophy, the conditional ablation of satellite cells by tamoxifen in Pax7-DTA 
mice did not attenuate the development of 100% hypertrophy induced by overload 
(McCarthy et al., 2011). It may well be that the microcirculation is crucial for the 
development of hypertrophy as it has been found that in genetically modified mice 
with muscle hypertrophy (due to myostatin knock out) and high-oxidative fibers 
(overexpression of oestrogen-related receptor gamma) the regenerative capacity was 
normal despite a lower satellite cell content, but higher capillary density (Omairi et 
al., 2016). Also in aged mice, the blunted hypertrophic response was associated not 
only associated with a lower satellite cell content (Ballak et al., 2015), but also with 
impaired angiogenesis (Ballak et al., 2016). These data suggest that impaired 
angiogenesis and/or reductions in the capillarization, that would result in an impaired 
delivery of substrates, of the muscle may underlie the impaired regenerative capacity 
and anabolic resistance in old age   
 
Extra stimulation of the mTORC1 pathway may overcome the anabolic blunting. As 
discussed above, older people need to ingest more protein than younger individuals to 
stimulate maximal MPS (Moore et al., 2015; Moore et al., 2009; Volpi, Mittendorfer, 
Rasmussen, Wolfe, 2000; Yang et al., 2012a). The greater activation of the mTORC1 
pathway when combining RT with protein/amino acid ingestion may inhibit MPD and 
augment MPS, thereby improving the hypertrophic response. The observation that 
 22 
BCAA administration attenuates the loss of body mass in mice bearing a cachexia-
inducing tumor (Eley, Russell, Tisdale, 2007) is promising and suggests that it may 
also enhance the hypertrophic response in this condition. Furthermore, HMB has been 
shown to attenuate the reduction in MPS in rodents following the administration of a 
cachectic stimulant (Aversa et al., 2011; Eley, Russell, Baxter, Mukerji, Tisdale, 
2007).  
 
In addition to RT and amino acid supplementation, various pharmaceutical therapies 
have been proposed to combat sarcopenia. Supplementation of the anabolic steroid, 
testosterone, augments muscle mass in older men, healthy hypogonadal men, older 
men with low testosterone levels, and men with chronic illness and low testosterone 
levels (Bhasin et al., 2006). It is thought that testosterone can reverse sarcopenia by 
suppressing skeletal muscle myostatin expression, while simultaneously stimulating 
the Akt pathway (Kovacheva, Hikim, Shen, Sinha, Sinha-Hikim, 2010) to increase 
MPS and decrease MPD. Furthermore, administration of a myostatin antagonist has 
led to satellite cell activation, increased MyoD protein expression, and greater muscle 
regeneration after injury in old murine skeletal muscle (Siriett et al., 2007).  
 
MUSCLE DAMAGE AND REPAIR 
In normal skeletal muscle, cytoskeletal proteins act as a framework that keeps the 
myofibrils aligned in a lateral position by connecting the Z-disks to one another and to 
the sarcolemma (Friden et al., 1984; Friden et al., 1983). Following eccentric exercise, 
Z-disk streaming (disturbance of Z-disk configuration) and misalignment of the 
myofibrils is a common characteristic (Friden et al., 1984). Eccentric contractions are 
defined as contractions where muscles lengthen as they exert force and generally 
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result in more muscle damage than concentric contractions (Clarkson, Hubal, 2002). It 
has been suggested that this is due to fewer motor units being recruited during 
eccentric exercise, leading to a smaller CSA of muscle being activated than during a 
concentric contraction at the same load (Enoka, 1996). It has also been demonstrated 
that the extent of muscle damage is due to strain (the change in length) rather than the 
amount of force generated by the muscle (Lieber, Friden, 1993; Lieber, Friden, 1999).  
 
Eccentric exercise not only causes alterations in the cytoskeletal structure, but also 
increases in the activity of proteolytic enzymes (Arthur, Booker, Belcastro, 1999; 
Kasperek et al., 1985; Stupka, Tarnopolsky, Yardley, Phillips, 2001). The positive 
correlation between the proteolytic enzyme activity and a rise in serum concentrations 
of muscle-specific proteins, e.g. creatine kinase (CK), post exercise (Arthur et al., 
1999; Kasperek et al., 1985; Stupka et al., 2001), suggests that the degree of 
activation of the proteolytic machinery is related to the degree of muscle damage. 
Therefore, it is feasible that the activity of these proteolytic enzymes may be required 
for the remodeling of skeletal muscle in response to exercise, where the regulated 
degradation of cellular proteins (Ordway, Neufer, Chin, DeMartino, 2000) may be a 
pre-requisite for subsequent adaptive repair and growth. 
 
There are three main systems that contribute to the controlled MPD following muscle 
damage; 1) the release of calpain, a non-lysosomal, Ca2+-dependent neutral protease 
that mediates the dismantling of myofibrils (Belcastro, Shewchuk, Raj, 1998), 2) the 
inflammatory response, which includes lysosomal proteolysis (Farges et al., 2002), 
and 3) the ATP-dependent UPP, which coordinates the demolition of protein 
fragments liberated by the aforementioned degradation systems (DeMartino et al., 
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1998). Recent findings suggest that myostatin is also implicated in the MPD process 
following damaging muscle contractions (Ochi et al., 2010).  
 
The calpain protein degradation system 
Calpain is a multidomain protein composed of two subunits, a catalytic 80-kDa 
subunit and a regulatory 30-kDa subunit (Suzuki, Sorimachi, Yoshizawa, Kinbara, 
Ishiura, 1995). In skeletal muscle, three homologous isozymes of calpain with 
different Ca2+ sensitivities have been identified (DeMartino et al., 1998): -calpain 
(active at micromolar Ca2+ concentrations), m-calpain (active at millimolar Ca2+ 
concentrations), and n-calpain (requiring very high Ca2+ concentrations). It appears 
that, although the - and m-calpain 80-kDa subunits are quite different, both have 
similar binding domains; the proteolytic site of a cysteine proteinase, the calpastatin 
(an endogenous inhibitor of calpain activity) binding domain, and the Ca2+-binding 
domain (Belcastro et al., 1996). The 30-kDa subunit is extremely hydrophobic, which 
may help to act as an anchor to the membrane proteins (Belcastro et al., 1996). While 
there is evidence to suggest calpain is localized and activated at or around the 
sarcolemma, thus targeting the membrane-associated proteins (Belcastro et al., 1998), 
others have demonstrated that calpain also targets Z-disk proteins, such as desmin and 
-actinin (Goll, Dayton, Singh, Robson, 1991). The action of other proteolytic 
complexes, including lysosomal enzymes and the UPP, may have a part to play in 
MPD immediately after damaging eccentric muscle contractions, but as their activity 
does not peak until later in the muscle damage/repair process (Belcastro et al., 1998; 
Kasperek et al., 1985), it is more likely that calpain and/or mechanical stress is the 
initial effector of cytoskeletal protein breakdown.  
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Calpain is activated by raised intracellular [Ca2+] (Belcastro et al., 1998). Initial 
mechanical damage to the sarcoplasmic reticulum (SR) and muscle plasma membrane 
caused by eccentric muscle contractions could lead to SR vacuolization and an 
increase in intracellular [Ca2+] (Clarkson et al., 2002; Warren, Hayes, Lowe, 
Armstrong, 1993). The intracellular [Ca2+] could rise further following an increased 
open probability of SACs as a consequence of increased strain on the skeletal muscle 
fibers during forced lengthening (Lieber et al., 1993). It is thought that the activation 
of calpain is pivotal in the breakdown of cytoskeletal proteins, including desmin and 
-actinin, rather than mechanical stress applied to the “over-stretched” sarcomeres 
during eccentric contractions per se (Belcastro et al., 1998). The activity of calpain is 
not only dependent on the intracellular [Ca2+] but also on the concentration of its 
inhibitor, calpastatin, and condition of degradable substrates, i.e. the ultrastructural 
proteins. To become fully active, calpain undergoes autolysis into its subunits. It is 
likely that the influx of excess Ca2+ into the muscle fiber (via the SACs, SR calcium 
channels and sarcolemmal lesions) binds to the specific domain on the 80-kDa calpain 
subunit, thereby inhibiting calpastatin. Once calpain is free of calpastatin, it may 
begin autolysis and/or bind to its substrate (with the help of Ca2+) and begin the 
process of MPD (Belcastro et al., 1996). A positive relationship between calpain 
activity and neutrophil accumulation within skeletal muscle after exercise suggests 
that the calpain-degraded protein fragments act as chemoattractants, thus localizing 
leukocytes to the site of muscle damage (Belcastro et al., 1998; Raj, Booker, 
Belcastro, 1998).  
 
The inflammatory response 
Exercise-induced damage to muscle fibers elicits an inflammatory response that 
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results in movement of fluid, plasma proteins and leukocytes to the site of injury 
(Clarkson et al., 2002). Leukocytes have the ability to break down intracellular 
proteins with the aid of lysosomal enzymes (Friden et al., 1984), but exactly how the 
inflammatory response regulates MPD and muscle repair following eccentric exercise 
is not entirely clear. However, the purpose of the post-exercise-induced inflammatory 
response is to promote clearance of damaged muscle tissue and prepare the muscle for 
repair (MacIntyre et al., 1995), a process that is sub-classified into acute and 
secondary inflammation. 
 
The acute phase response in skeletal muscle begins with the ‘complement system’ 
when fragments from the damaged fiber(s) serve as chemoattractants, luring 
leukocytes to the injured area (Belcastro et al., 1998; Evans et al., 1991). As a 
consequence there is an accumulation of neutrophils, the histological hallmark of 
acute inflammation (MacIntyre et al., 1995), in and around the site of injury, which 
peaks around 4 hours after exercise-induced damage has occurred (Evans et al., 
1991). The accumulation of neutrophils has been reported to be more significant after 
eccentric than concentric exercise, and is most likely related to the degree of damage 
incurred (Evans et al., 1991). Pro-inflammatory cytokines, such as IL-1, IL-6, TNF-, 
and acute phase proteins, e.g. CRP, act as mediators of inflammatory reactions. TNF-
 induces the production of ROS, altering vascular permeability, which leads to 
leukocyte infiltration into the muscle fiber (Evans et al., 1991). TNF- also stimulates 
the release of cytoxic factors from neutrophils, such as lysozymes and ROS (Friden et 
al., 1984; MacIntyre et al., 1995), which are responsible for at least a part of the MPD 
process following exercise-induced damage (Friden et al., 1984; Kasperek et al., 
1985).  
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It may take up to seven days to see a significant infiltration of monocytes (precursors 
to macrophages) within the damaged muscle fiber (Evans et al., 1991), which carry 
out further phagocytic activity inside the muscle fiber. Furthermore, considerable 
increases in the quantity of lipofuscin granules (generally considered to be the 
indigestible residue of lysosomal degradation) in sore muscles three days after 
exercise suggests that lysozyme activity plays a major part in the secondary 
inflammatory process (Farges et al., 2002; Friden, 1984). The role of the 
inflammatory response in muscle regeneration is therefore thought to be the further 
breakdown of damaged muscle proteins via lysozymes, the engulfing of protein 
fragments by macrophages and the activation of the UPP by the pro-inflammatory 
cytokines released from the neutrophils. These cytokines simultaneously stimulate the 
proliferation of satellite cells, crucial for the regeneration of the damaged area (Chen, 
Jin, Li, 2007). 
 
The ubiquitin-proteasome pathway 
This pathway is recognized as the major non-lysosomal complex responsible for the 
degradation of cellular proteins. The UPP has received much attention due to its 
involvement in cellular processes, where protein degradation is a key regulatory or 
adaptive event (Attaix et al., 1998; Attaix, Combaret, Pouch, Taillandier, 2001; 
Ciechanover, 1994). There are two types of ubiquitin in human skeletal muscle: free 
and conjugated (Thompson, Scordilis, 1994). In its free state ubiquitin is a normal 
component of the non-stressed muscle fiber but it also forms complexes, or 
conjugations, with abnormal proteins and then returns to its free state (Fig. 3). The 
conjugation of ubiquitin with denatured proteins within the muscle fiber “tags” these 
 28 
proteins for recognition by a non-lysosomal protease to be subsequently degraded in a 
process that requires ATP (Attaix et al., 1998). The UPP, therefore, consists of two 
major components that represent the system’s functionally distinct parts. Ubiquitin is 
the element that covalently binds to the protein due to be broken down, while the 26S 
proteasome, a large protease complex, catalyses the degradation of the ubiquitin-
tagged proteins (DeMartino et al., 1998).  
 
[FIGURE 3 NEAR HERE] 
 
The cellular proteins are selected for degradation by the attachment of multiple 
molecules of ubiquitin, or a polyubiquitin chain, which is built by repeated cycles of 
conjugation via the action of E1, E2, and E3 conjugating enzymes (Fig. 3). Ubiquitin 
is initially activated in the presence of ATP by the ubiquitin-activating enzyme, E1, 
which then transfers ubiquitin to E2, one of the ubiquitin-conjugating enzymes. E2 
then binds the ubiquitin molecule to the protein substrate, which is selected for 
tagging by E3 (Attaix et al., 2001). The 26S proteasome is able to discriminate 
between ubiquitinated and non-ubiquitinated proteins, and rapidly degrades the 
polyubiquitinated proteins, deriving the energy for this process from ATP hydrolysis 
(Hershko, Ciechanover, 1998).  
 
The 26S proteasome is composed of a 20S proteasome and two 19S (PA700) 
regulatory modules (Attaix et al., 2001; Ciechanover, 1994; DeMartino et al., 1998). 
The 20S proteasome is the proteolytic core, containing multiple catalytic sites. PA700 
binds to each end of the proteasome cylinder and elicits ATPase activity in order to 
unfold and/or translocate the ubiquitinated proteins to the catalytic sites within the 
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20S proteasome (Fig. 3). PA700 is also thought to be responsible for disassembling 
the polyubiquitinated chain, a process requiring its isopeptidase activity.  
 
The total amount of ubiquitin found in skeletal muscle is muscle fiber-type specific, 
with a greater abundance of ubiquitin found in type I fibers (Riley et al., 1992). 
Furthermore, a three to seven times higher density of conjugated ubiquitin was found 
at the Z-discs than anywhere else in the muscle fiber, which suggests that, like 
calpain, ubiquitin targets the cytoskeletal proteins of muscle fibers. One main 
difference between the two systems, however, is that calpain is activated a lot earlier 
than the ubiquitin-proteasome pathway (Feasson et al., 2002; Stupka et al., 2001). 
Furthermore, the action of the UPP may be prolonged post-exercise in order to 
increase the intracellular concentration of amino acids (Tipton, Wolfe, 1998), which 
would stimulate MPS via mTORC1 activation.  
 
Repair following exercise-induced muscle damage 
Following the orderly demolition of damaged/cleaved muscle proteins (via the 
aforementioned MPD systems) in response to eccentric contractions, the damaged 
muscle fibers need to undergo repair. The activation, proliferation and fusion of 
satellite cells with damaged muscle fibers, and the subsequent differentiation into 
myoblasts, are crucial for this repair process (McCarthy et al., 2011; Petrella et al., 
2006). In fact, it has been shown that while the hypertrophic response maybe 
maintained in the absence of satellite cell recruitment, recovery from damage was 
severely impaired under these conditions (McCarthy et al., 2011). 
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As previously discussed, IGF-I and MRFs are integral in the activation and 
differentiation of satellite cells (Langen et al., 2004; Scime et al., 2006; Szalay et al., 
1997), which probably explains why skeletal muscle IGF-I and MRF expression are 
increased following stretch-induced damage (Bickel et al., 2005; Petrella et al., 2006; 
Yang, Alnaqeeb, Simpson, Goldspink, 1997; Yang, Creer, Jemiolo, Trappe, 2005). To 
repair the muscle, satellite cells fuse with damaged fibers and differentiate into 
myonuclei, but may even form new fibers in the case of complete fiber necrosis. The 
orderly proliferation and subsequent differentiation is crucial for optimal repair. For 
the initial proliferation of satellite cells the inflammatory environment is beneficial, 
but this inflammation must be transient to allow the cells to differentiate (Pelosi et al., 
2007). Therefore, it may be that chronic low-grade systemic inflammation, e.g. during 
ageing, may underlie the delay in muscle regeneration (Langen et al., 2006).  
 
SUMMARY 
Skeletal muscle is able to hypertrophy in response to a variety of anabolic stimuli, 
which include resistance exercise, amino acid ingestion, and an increase in IGF-I 
expression. All these stimuli are able to activate the mTORC1 signaling pathway, 
which stimulates MPS and inhibits MPD. When the rate of MPS exceeds MPD, there 
is a positive net protein balance (NPB) and an accretion of contractile material occurs, 
leading to muscle hypertrophy and an increase in strength. Inducing muscle 
hypertrophy can have beneficial effects on individuals suffering from cachectic 
conditions, such as cancer, AIDS, and sarcopenia, where muscle atrophy can have 
devastating effects on an individual’s quality of life. Muscle atrophy occurs when 
there is a negative NPB, i.e. when the rate of MPD is greater than MPS. There are a 
number of stimuli that have been associated with muscle atrophy, including 
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chronically elevated levels of pro-inflammatory cytokines (e.g. IL-1, IL-6 and TNF-
), a reduction in IGF-I and increased expression of myostatin. Furthermore, 
strenuous unaccustomed exercise can cause mechanical damage to the muscle, which 
activates MPD systems, including calpain, inflammation and the ubiquitin-proteasome 
protein degradation pathway. Damaged proteins within the muscle fiber are broken 
down, resulting in an increased intracellular amino acid concentration, which in turn 
activates mTORC1 and increases MPS, thus helping to repair the muscle. Elevated 
local IGF-I and MRF expression facilitates the repair process by activating satellite 
cells and enabling fusion with existing fibers. Many of the molecular signaling 
pathways associated with muscle hypertrophy, atrophy and repair have been 
identified. However, there is still much to be learned about these pathways, and 
understanding them may help us to prevent or reverse muscle atrophy associated with 
a host of muscle wasting conditions.   
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FIGURE LEGENDS 
Figure 1. The molecular signaling pathways associated with muscle hypertrophy and atrophy. 
The binding of IGF-I to its receptor (IGF-IR) causes autophosphorylation of insulin receptor substrate 
(IRS1). Phosphatidylinositol 3-kinase (PI3K) is a lipid kinase that phosphorylates phosphatidylinositol 
(4,5)-bisphosphate, producing phosphatidylinositol (3,4,5)-trisphosphate, which is a membrane-binding 
site for phosphoinositide-dependent protein kinase (PDK1). Upon translocation to the sarcolemma, 
AKT (or protein kinase B, PKB) is phosphorylated by PDK1. Once activated, AKT phosphorylates 
mammalian target of rapamycin complex 1 (mTORC1) directly and by phosphorylating and 
inactivating the tuberous sclerosis complexes 1 and 2 (TSC1/2), which otherwise inhibit mTORC1 
activation. Following resistance exercise, an influx of calcium ions (Ca2+) via stretch-activated 
channels (SACs) and the activation of FAK in the costamere can inactivate TSC1/2, thus activating 
mTORC1. Amino acids entering the muscle fiber cause RagGTPase-dependent translocation of 
mTORC1 to the lysosome, where it is activated by ras homologous protein enriched in brain (Rheb). 
mTORC1 subsequently activates 70KDa ribosomal S6 protein kinase (p70S6K), and inhibits 4E-BP 
(also known as PHAS-1), which is a negative regulator of the eukaryotic translation initiation factor 4E 
(eIF-4E). Phosphorylated AKT also inhibits glycogen-synthase kinase 3β (GSK3β), a substrate of AKT 
that blocks protein translation initiated by the eIF-2B protein. All of these actions lead to increased 
protein synthesis. However, protein degradation can be induced by pro-inflammatory cytokines, such 
as tumour necrosis factor-α (TNF-α) and interleukin-6 (IL-6), which activate NF-κB via degradation of 
I-κB, leading to increased transcription of the E3 ubiquitin-ligase, muscle RING-finger protein-1 
(MuRF1). Another ligase, Atrogin1 (also known as MAFbx), is up-regulated by mitogen-activated 
protein kinase (MAPK) p38, while both ligases are up-regulated by forkhead box (FOXO) transcription 
factors. However, phosphorylated AKT blocks the transcriptional up-regulation of Atrogin1 and 
MuRF1 by inhibiting FOXO1, while phosphorylated mTORC1 inhibits the up-regulation of Atrogin1 
directly. Myostatin also increases protein degradation and decreases protein synthesis by activating 
MAPKs and the SMAD complex, and by inhibiting PI3K. In addition, myostatin inhibits the myogenic 
program, thus resulting in a decrease of myoblast proliferation.  
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Figure 2. Schematic representation of (A) the location of costameres within a skeletal muscle 
fiber and (B) the proteins that constitute the costamere. Costameres are protein complexes 
circumferentially aligned along the length of the muscle fiber that connect peripheral myofibrils at the 
Z-disks to the sarcolemma and beyond to the extra-cellular matrix (ECM). The costamere comprises a 
dystrophin/glycoprotein complex and a focal adhesion complex (FAC), which includes the integrin-
associated tyrosine kinase focal adhesion kinase (FAK). Fig. 2B modified from (Fluck et al., 2002) 
with permission.  
 
Figure 3. Breakdown of the protein fragment via the ubiquitin proteasome pathway. Multiple 
ubiquitin (Ub) molecules form a polyubiquitin chain in a process involving the Ub-activating (E1), Ub-
conjugating (E2), and Ub-ligating (E3) enzymes. The targeted protein fragment is then selected for 
degradation, or “tagged”, via the covalent attachment of the polyubiquitin chain. The tagging enables 
the 19S (PA700) module to recognize the protein fragment, so that it can be further degraded by the 
20S core into oligopeptides after it has been de-ubiquitinated and the Ub molecules released recycled. 
Adapted from (Milacic, Dou, 2009) with permission.  
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